Clinical Research Directory
Browse clinical research sites, groups, and studies.
Personalized DC Vaccine for Postoperative Cancer
Sponsor: Sichuan University
Summary
The study is aimed to the test efficacy and safety of neoantigen-primed dendritic cell (DC) cell vaccine therapy for postoperative locally advanced gastric cancer, hepatocellular carcinoma, lung cancer and colorectal cancer, and to explore the biomarkers related to efficacy and adverse event.
Official title: Adjuvant Treatment in Cancer Patients with Neoantigen-primed DC Vaccine : a Single-arm, Open-label, Prospective Clinical Trial
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2019-06-01
Completion Date
2026-06-01
Last Updated
2025-02-28
Healthy Volunteers
No
Interventions
DC vaccine subcutaneous administration
subcutaneous administration
Locations (1)
Qiu Li
Chengdu, Sichuan, China